Get notified when TNYA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TNYA Tenaya Therapeutics, Inc. 8-K

Tenaya Therapeutics reports Q4 and full year 2025 financial results

Filed March 11, 2026 · Period ending March 11, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release announcing financial results for the quarter and full year ended December 31, 2025. Specific financial figures and operational updates are contained in the attached press release.

  • low

    This is a procedural 8-K filing that formally attaches the earnings press release to the public record. No additional material business events disclosed in the filing body.

    8-K: Results of Operations verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade TNYA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify